C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
SMG Equity

Scotts Miracle-Gro

NYSE · SMG

$62.91
+1.37%
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
54/100 composite
Fundamentals75
Regulatory53
Market40
Editorial30
Composite · trailing 12 months

Scotts Miracle-Gro carries a Neutral rating, with a composite score of 54 out of 100 and a conviction reading of 2 of 5. Weights are locked at 35 percent fundamentals, 25 percent regulatory, 25 percent market, and 15 percent editorial, and each pillar is broken out for direct review. The fundamentals pillar contributes the largest share at 75, pulling the composite into the middle of the band. Opposite that, editorial prints only 30, and is what keeps the rating anchored where it is.

The scoring inputs are concrete: reported revenue growth of 5.0 percent year over year, an operating margin of 27.7 percent, a filing cadence of 1 regulator events in the trailing 90 days. Together they explain most of the pillar mix. Inputs are limited to primary regulatory filings, licensed fundamentals data, and institutional pricing feeds, plus a density read from CIN newsroom coverage. The rating enables direct comparison across the 336 tickers in the CIN coverage universe on a consistent, deterministic basis, and refreshes on a scheduled cadence tied to the primary-source ingest cycle.

The clearest catalyst is the next quarterly print. Fundamentals contribute 75 of the composite, and either an acceleration in top-line growth or a stabilization of the operating margin would move the score higher; a deterioration on either would compress it.

Scored: 2026-07-14Valid through: 2026-08-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
IR / PR agency
n.a. (In-house)
IR email
investor@scotts.com
IR page
Investor relations
Corporate DetailsCompany profile
Headquarters
14111 SCOTTSLAWN ROAD, MARYSVILLE, OH, 43041
Phone
9376440011
CEO
Nate Baxter
CFO
Mark Scheiwer
SEC CIK
825542
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$3.81B
Enterprise value
$6.15B
P/E ratio
18.8
PEG ratio
0.90
Price to book
21.95
Price to sales
1.10
EV / EBITDA
12.39
Revenue (TTM)
$3.47B
Gross profit (TTM)
$1.13B
EBITDA
$561.9M
Operating margin
27.7%
Profit margin
3.2%
Rev growth YoY
5.0%
Return on equity
-47.6%
Return on assets
8.8%
EPS (TTM)
$3.48
EPS est. current year
$4.34
Wall St. target price
$73.00
Dividend per share
$2.64
Dividend yield
4.05%
Shares outstanding
58.2M
Insider ownership
23.7%
Institutional ownership
81.9%
Beta
1.80
Full-time employees
5,200
GICS sector
Basic Materials
GICS industry
Agricultural Inputs
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Scotts Miracle-Gro (SMG)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Scotts Miracle-Gro (SMG), a cannabis-sector equity listed on NYSE. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

Analyst average price target $76.6.

CIN editorial stance: Neutral / Wait. Mixed data profile. Risk factors: insider selling. (2 bullish signals, 2 bearish signals.)

Bullish and bearish analyst opinions for The Scotts Miracle-Gro Company (SMG)

Bullish view. The Scotts Miracle-Gro core lawn-and-garden brand throws off cash while Hawthorne (cannabis-cultivation supplies) has become a call option; bulls model a return to Hawthorne growth as the US wholesale glut clears.

Bearish view. Skeptics point to elevated leverage, weather-dependent sell-through, and years of Hawthorne inventory de-stocking that has yet to fully normalize.

Live ratings, price targets, and consensus figures for The Scotts Miracle-Gro Company appear above this summary. Explore analyst coverage across the 326-equity cannabis universe.

Latest price: $62.91 (+1.37%) on NYSE.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for SMG are maintained by Cannabis Investor News and refreshed throughout the trading day.